The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Human Osteoclast-Poor Osteopetrosis with Hypogammaglobulinemia due to TNFRSF11A (RANK) Mutations
Open accessAbstract
Autosomal-Recessive Osteopetrosis (ARO) comprises a heterogeneous group of bone diseases for which mutations in five genes are known as causative. Most ARO are classified as osteoclast-rich, but recently a subset of osteoclast-poor ARO has been recognized as due to a defect in TNFSF11 (also called RANKL or TRANCE, coding for the RANKL protein), a master gene driving osteoclast differentiation along the RANKL-RANK axis. RANKL and RANK (coded for by the TNFRSF11A gene) also play a role in the immune system, which raises the possibility that defects in this pathway might cause osteopetrosis with immunodeficiency. From a large series of ARO patients we selected a Turkish consanguineous family with two siblings affected by ARO and hypogammaglobulinemia with no defects in known osteopetrosis genes. Sequencing of genes involved in the RANKL downstream pathway identified a homozygous mutation in the TNFRSF11A gene in both siblings. Their monocytes failed to differentiate in vitro into osteoclasts upon exposure to M-CSF and RANKL, in keeping with an osteoclast-intrinsic defect. Immunological analysis showed that their hypogammaglobulinemia was associated with impairment in immunoglobulin-secreting B cells. Investigation of other patients revealed a defect in both TNFRSF11A alleles in six additional, unrelated families. Our results indicate that TNFRSF11A mutations can cause a clinical condition in which severe ARO is associated with an immunoglobulin-production defect.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In contrast to “osteoclast-rich” OPT, active bone formation is lacking in “osteoclast-poor” OPT (due to TNFRSF11A mutations226) or dysosteosclerosis (DSS) (an OPT of unknown etiology227).”
From Bone remodeling: an operational process ensuring survival and bone mechanical competence (2022) · cites this paper as [226]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph node organogenesis.
Kong, Y.-Y., Yoshida, H., Sarosi, I., Tan, H.-L., Timms, E., Capparelli, C., Morony, S., Oliveira-dos-Santos, A. J., Van, G., Itie, A., et al. (1999) · Nature · doi:10.1038/16852 · Cited by 3,351
RANK is essential for osteoclast and lymph node development.
Dougall, W. C., Glaccum, M., Charrier, K., Rohrbach, K., Brasel, K., De Smedt, T., Daro, E., Smith, J., Tometsko, M. E., Maliszewski, C. R., et al. (1999) · Genes & Development · doi:10.1101/gad.13.18.2412 · Cited by 1,478
The molecular understanding of osteoclast differentiation
Asagiri, M., & Takayanagi, H. (2007) · Bone · doi:10.1016/j.bone.2006.09.023 · Cited by 1,363
Loss of the ClC-7 Chloride Channel Leads to Osteopetrosis in Mice and Man
Kornak, U., Kasper, D., Bösl, M. R., Kaiser, E., Schweizer, M., Schulz, A., Friedrich, W., Delling, G., & Jentsch, T. J. (2001) · Cell · doi:10.1016/s0092-8674(01)00206-9 · Cited by 995
X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-κB signaling
Döffinger, R., Smahi, A., Chable-Bessia, C., Geissmann, F., Feinberg, J. M., Durandy, A., Bodemer, C., Kenwrick, S., Dupuis‐Girod, S., Blanche, S., et al. (2001) · Nature Genetics · doi:10.1038/85837 · Cited by 842
Self-citationFrattini, A., Orchard, P. J., Sobacchi, C., Giliani, S. C., Abinun, M., Mattsson, J. P., Keeling, D. J., Andersson, A., Wallbrandt, P., Zecca, L., et al. (2000) · Nature Genetics · doi:10.1038/77131 · Cited by 669
Self-citationTolar, J., Teitelbaum, S. L., & Orchard, P. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmra040952 · Cited by 500
Self-citationRossi, S. W., Kim, M., Leibbrandt, A., Parnell, S. M., Jenkinson, W. E., Glanville, S. H., McConnell, F. M., Scott, H. S., Penninger, J. M., Jenkinson, E. J., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062497 · Cited by 491
Mutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis
Hughes, A. E., Ralston, S. H., Marken, J., Bell, C., Macpherson, H. K., Wallace, R. G. H., Hul, W. V., Whyte, M. P., Nakatsuka, K., Hovy, L., et al. (2000) · Nature Genetics · doi:10.1038/71667 · Cited by 484
Osteoclast-poor human osteopetrosis due to mutations in the gene encoding RANKL
Sobacchi, C., Frattini, A., Guerrini, M. M., Abinun, M., Pangrazio, A., Susani, L., Bredius, R. G. M., Mancini, G. M. S., Cant, A. J., Bishop, N. J., et al. (2007) · Nature Genetics · doi:10.1038/ng2076 · Cited by 389
Self-citation
Cited by
Sorted by citations
Denosumab and bisphosphonates: Different mechanisms of action and effects
Baron, R., Ferrari, S., & Russell, R. G. G. (2010) · Bone · doi:10.1016/j.bone.2010.11.020 · Cited by 738
RANKL biology: bone metabolism, the immune system, and beyond
Ono, T., Hayashi, M., Sasaki, F., & Nakashima, T. (2020) · Inflammation and Regeneration · doi:10.1186/s41232-019-0111-3 · Cited by 597
Osteopetrosis: genetics, treatment and new insights into osteoclast function
Sobacchi, C., Schulz, A., Coxon, F. P., Villa, A., & Helfrich, M. H. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.137 · Cited by 580
Self-citationAn overview of the regulation of bone remodelling at the cellular level
Kular, J., Tickner, J. C., Chim, S. M., & Xu, J. (2012) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2012.03.021 · Cited by 568
Osteoimmunology: The conceptual framework unifying the immune and skeletal systems
Okamoto, K., Nakashima, T., Shinohara, M., Negishi-Koga, T., Komatsu, N., Terashima, A., Sawa, S., Nitta, T., & Takayanagi, H. (2017) · Physiological Reviews · doi:10.1152/physrev.00036.2016 · Cited by 534
Feng, X., & Teitelbaum, S. L. (2013) · Bone Research · doi:10.4248/br201301003 · Cited by 562
Crockett, J. C., Rogers, M. J., Coxon, F. P., Hocking, L. J., & Helfrich, M. (2011) · Journal of Cell Science · doi:10.1242/jcs.063032 · Cited by 532
Self-citationBone remodeling: an operational process ensuring survival and bone mechanical competence
Bolamperti, S., Villa, I., & Rubinacci, A. (2022) · Bone Research · doi:10.1038/s41413-022-00219-8 · Cited by 482
Stark, Z., & Savarirayan, R. (2009) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-4-5 · Cited by 463
Ralston, S. H., & Uitterlinden, A. G. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0044 · Cited by 396
Ishigaki, K., Sakaue, S., Terao, C., Luo, Y., Sonehara, K., Yamaguchi, K., Amariuta, T., Too, C. L., Laufer, V. A., Scott, I. C., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01213-w · Cited by 347
New insights into osteoclastogenic signaling mechanisms
Nakashima, T., Hayashi, M., & Takayanagi, H. (2012) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2012.05.005 · Cited by 359
Genetics of osteoporosis from genome-wide association studies: advances and challenges
Richards, J. B., Zheng, H., & Spector, T. D. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3228 · Cited by 312
The role of cytokines in inflammatory bone loss
de Souza, P. C., & Lerner, U. H. (2013) · Immunological Investigations · doi:10.3109/08820139.2013.822766 · Cited by 278
Cathepsin K Inhibitors for Osteoporosis: Biology, Potential Clinical Utility, and Lessons Learned
Drake, M. T., Clarke, B. L., Oursler, M. J., & Khosla, S. (2017) · Endocrine Reviews · doi:10.1210/er.2015-1114 · Cited by 291
Central control of fever and female body temperature by RANKL/RANK
Hanada, R., Leibbrandt, A., Hanada, T., Kitaoka, S., Furuyashiki, T., Fujihara, H., Trichereau, J., Paolino, M., Qadri, F., Plehm, R., et al. (2009) · Nature · doi:10.1038/nature08596 · Cited by 243
Henriksen, K., Bollerslev, J., Everts, V. E., & Karsdal, M. A. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0006 · Cited by 236
Osteoimmunology: Crosstalk Between the Immune and Bone Systems
Nakashima, T., & Takayanagi, H. (2009) · Journal of Clinical Immunology · doi:10.1007/s10875-009-9316-6 · Cited by 218
A Genome-Wide Association Study of Myasthenia Gravis
Renton, A. E., Pliner, H. A., Provenzano, C., Evoli, A., Ricciardi, R., Nalls, M. A., Marangi, G., Abramzon, Y. A., Arepalli, S., Chong, S., et al. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2014.4103 · Cited by 206
RANKL as the master regulator of osteoclast differentiation
Takayanagi, H. (2021) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-020-01191-1 · Cited by 175
Nagy, V., & Penninger, J. M. (2015) · Gerontology · doi:10.1159/000371845 · Cited by 175
Infantile Malignant, Autosomal Recessive Osteopetrosis: The Rich and The Poor
VILLA, A. M., Guerrini, M. M., Cassani, B., Pangrazio, A., & Sobacchi, C. (2008) · Calcified Tissue International · doi:10.1007/s00223-008-9196-4 · Cited by 164
Self-citationDo RANKL inhibitors (denosumab) affect inflammation and immunity?
Ferrari, S., & Ferrari, S. (2010) · Osteoporosis International · doi:10.1007/s00198-010-1326-y · Cited by 158
Grigoriadis, A. E., Kennedy, M., Bozec, A., Brunton, F., Stenbeck, G., Park, I.-H., Wagner, E. F., & Keller, G. M. (2010) · Blood · doi:10.1182/blood-2009-07-234690 · Cited by 151
Advances in osteoclast biology reveal potential new drug targets and new roles for osteoclasts
Boyce, B. F. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1885 · Cited by 153
Osteoclast-Derived Coupling Factors in Bone Remodeling
Henriksen, K., Karsdal, M. A., & Martin, T. J. (2013) · Calcified Tissue International · doi:10.1007/s00223-013-9741-7 · Cited by 146
Crockett, J. C., Mellis, D. J., Scott, D. I., & Helfrich, M. H. (2011) · Osteoporosis International · doi:10.1007/s00198-010-1272-8 · Cited by 143
Self-citationHanada, R., Hanada, T., Sigl, V., Schramek, D., & Penninger, J. M. (2011) · Journal of Molecular Medicine · doi:10.1007/s00109-011-0749-z · Cited by 147
OsteoimmunologyPreprint
Okamoto, K., & Takayanagi, H. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a031245 · Cited by 146
Structural and Functional Insights of RANKL–RANK Interaction and Signaling
Liu, C., Walter, T. S., Huang, P., Zhang, S., Zhu, X., Wu, Y., Wedderburn, L. R., Tang, P., Owens, R. J., Stuart, D. I., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0904033 · Cited by 142
Osteoclasts and odontoclasts: signaling pathways to development and disease
Wang, Z., & McCauley, L. K. (2010) · Oral Diseases · doi:10.1111/j.1601-0825.2010.01718.x · Cited by 132
The anti-tumor effect of RANKL inhibition in malignant solid tumors – A systematic review
de Groot, A. F., Appelman‐Dijkstra, N. M., van der Burg, S. H., & Kroep, J. R. (2017) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2017.10.010 · Cited by 134
Advances in osteoclast biology resulting from the study of osteopetrotic mutations
Segovia‐Silvestre, T., Neutzsky-Wulff, A. V., Sørensen, M. G., Christiansen, C., Bollerslev, J., Karsdal, M. A., & Henriksen, K. (2008) · Human Genetics · doi:10.1007/s00439-008-0583-8 · Cited by 128
Osteoporosis and Bone Mass Disorders: From Gene Pathways to Treatments
Rivadeneira, F., & Mäkitie, O. (2016) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2016.03.006 · Cited by 124
Palagano, E., Menale, C., Sobacchi, C., & VILLA, A. M. (2018) · Current Osteoporosis Reports · doi:10.1007/s11914-018-0415-2 · Cited by 134
Self-citationAn SNX10 mutation causes malignant osteopetrosis of infancy
Aker, M., Rouvinski, A., Hashavya, S., Ta‐Shma, A., Shaag, A., Zenvirt, S., Israel, S., Weintraub, M., Taraboulos, A., Bar‐Shavit, Z., et al. (2012) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2011-100520 · Cited by 118
Mellis, D. J., Itzstein, C., Helfrich, M., & Crockett, J. C. (2011) · Journal of Endocrinology · doi:10.1530/joe-11-0212 · Cited by 117
Self-citationEverts, V. E., de Vries, T. J., & Helfrich, M. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.05.004 · Cited by 108
Self-citationThe immune system, bone and RANKL
Guerrini, M. M., & Takayanagi, H. (2014) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2014.06.003 · Cited by 116
Self-citationRegulation of bone by the adaptive immune system in arthritis
Okamoto, K., & Takayanagi, H. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3323 · Cited by 107
Epigenetic and transcriptional regulation of osteoclast differentiation
Kurotaki, D., Yoshida, H., & Tamura, T. (2020) · Bone · doi:10.1016/j.bone.2020.115471 · Cited by 101
PLEKHM1/DEF8/RAB7 complex regulates lysosome positioning and bone homeostasis
Fujiwara, T., Ye, S., Castro-Gomes, T., Winchell, C. G., Andrews, N. W., Voth, D. E., Varughese, K. I., Mackintosh, S. G., Feng, Y., Pavlos, N., et al. (2016) · JCI Insight · doi:10.1172/jci.insight.86330 · Cited by 92
Mechanisms of osteoclast-dependent bone formation
Teti, A. M. (2013) · BoneKEy Reports · doi:10.1038/bonekey.2013.183 · Cited by 94
Ralston, S. H. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05317.x · Cited by 92
A single‐center experience in 20 patients with infantile malignant osteopetrosis
Mazzolari, E., Forino, C., Razza, A., Porta, F., VILLA, A. M., & Notarangelo, L. D. (2009) · American Journal of Hematology · doi:10.1002/ajh.21447 · Cited by 89
Self-citationGrabowski, P. (2009) · Endocrine development · doi:10.1159/000223687 · Cited by 89
Nuclear Receptors in Bone Physiology and Diseases
Imai, Y., Youn, M., Inoue, K., Takada, I., Kouzmenko, A., & Kato, S. (2013) · Physiological Reviews · doi:10.1152/physrev.00008.2012 · Cited by 95
Osteoclasts and the immune system
Nakashima, T., & Takayanagi, H. (2009) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-009-0089-z · Cited by 88
Weivoda, M. M., Ruan, M. M., Pederson, L. G., Hachfeld, C. M., Davey, R. A., Zajac, J. D., Westendorf, J. J., Khosla, S., & Oursler, M. J. (2015) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2586 · Cited by 83
New roles of osteoblasts involved in osteoclast differentiation
Yamashita, T. (2012) · World Journal of Orthopedics · doi:10.5312/wjo.v3.i11.175 · Cited by 82
Ta, H. M., Nguyen, G. T. T., Jin, H. M., Choi, J., Park, H., Kim, N., Hwang, H., & Kim, K. K. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011686107 · Cited by 78
Henriksen, K., Flores, C., Thomsen, J. S., Brüel, A.-M., Thudium, C. S., Neutzsky-Wulff, A. V., Langenbach, G. E. J., Sims, N., Askmyr, M., Martin, T. J., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027482 · Cited by 77
Pangrazio, A., Cassani, B., Guerrini, M. M., Crockett, J. C., Marrella, V., Zammataro, L. A., Strina, D., Schulz, A., Schlack, C., Kornak, U., et al. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.559 · Cited by 75
Self-citationBoudin, E., Fijałkowski, I., Hendrickx, G., & Hul, W. V. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.12.021 · Cited by 77
Seldin, M. F., Alkhairy, O. K., Lee, A. T., Lamb, J. A., Sussman, J. D., Pirskanen, R., Piehl, F., Verschuuren, J. J. G. M., Kostera‐Pruszczyk, A., Szczudlik, P., et al. (2015) · Molecular Medicine · doi:10.2119/molmed.2015.00232 · Cited by 75
One Disease, Many Genes: Implications for the Treatment of Osteopetroses
Penna, S., Capo, V., Palagano, E., Sobacchi, C., & VILLA, A. M. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00085 · Cited by 78
Self-citationBoyce, R. W., Varela, A., Chouinard, L., Bussiere, J. L., Chellman, G. J., Ominsky, M. S., & Pyrah, I. T. G. (2014) · Bone · doi:10.1016/j.bone.2014.04.002 · Cited by 70
Genetics in Endocrinology: Autosomal dominant osteopetrosis revisited: lessons from recent studies
Bollerslev, J., Henriksen, K., Nielsen, M. F., Brixen, K., & Hul, W. V. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0136 · Cited by 70
Osteopetroses, emphasizing potential approaches to treatment
Teti, A. M., & Econs, M. J. (2017) · Bone · doi:10.1016/j.bone.2017.02.002 · Cited by 69
RANKL and RANK in sex hormone-induced breast cancer and breast cancer metastasis
Schramek, D., Sigl, V., & Penninger, J. M. (2011) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2011.02.007 · Cited by 73
Pangrazio, A., Fasth, A. L., Sbardellati, A., Orchard, P. J., Kasow, K. A., Raza, J., Albayrak, C., Albayrak, D., Vanakker, O. M., Moerloose, B. D., et al. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1849 · Cited by 67
Self-citationNovel insights into the coupling of osteoclasts and resorption to bone formation
Durdan, M., Azaria, R. D., & Weivoda, M. M. (2021) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2021.10.008 · Cited by 69
The RANKL-RANK Axis: A Bone to Thymus Round Trip
Sobacchi, C., Menale, C., & VILLA, A. M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00629 · Cited by 65
Self-citationBone effects of vitamin D – Discrepancies between in vivo and in vitro studies
Suda, T., Takahashi, F., & Takahashi, N. (2011) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2011.11.011 · Cited by 66
Osteoclasts in arthritis and Th17 cell development
Okamoto, K., & Takayanagi, H. (2010) · International Immunopharmacology · doi:10.1016/j.intimp.2010.11.010 · Cited by 66
Paget's Disease of Bone: Evidence for Complex Pathogenetic Interactions
Chung, P. Y. J., & Hul, W. V. (2011) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2011.07.005 · Cited by 63
Titanji, K. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01851 · Cited by 61
Development and Function of Murine B Cells Lacking RANK
Perlot, T., & Penninger, J. M. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102063 · Cited by 63
RANK as a therapeutic target in cancer
González‐Suárez, E., & Sanz‐Moreno, A. (2016) · FEBS Journal · doi:10.1111/febs.13645 · Cited by 59
Bone-derived factors mediate crosstalk between skeletal and extra-skeletal organs
He, T., Qin, L., Chen, S., Huo, S., Li, J., Zhang, F., Yi, W., Mei, Y., & Xiao, G. (2025) · Bone Research · doi:10.1038/s41413-025-00424-1 · Cited by 58
RANKL/RANK – From bone physiology to breast cancer
Sigl, V., & Penninger, J. M. (2014) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2014.01.002 · Cited by 59
Alabdullatif, M., Dhaibani, M. A. A., Khassawneh, M. Y., & El‐Hattab, A. W. (2016) · Clinical Genetics · doi:10.1111/cge.12872 · Cited by 56
Heritable sclerosing bone disorders
de Vernejoul, M. C., & Kornak, U. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05244.x · Cited by 54
High-Dose Diosgenin Reduces Bone Loss in Ovariectomized Rats via Attenuation of the RANKL/OPG Ratio
Zhang, Z., Song, C., Fu, X., Liu, M., Li, Y., Pan, J., Liu, H., Wang, S., Xiang, L., Xiao, G. G., et al. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms150917130 · Cited by 56
Castañeda, B., Simon, Y., Jacques, J. A., Hess, E., Choi, Y., Blin‐Wakkach, C., Mueller, C. G., Berdal, A., & Lézot, F. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22305 · Cited by 52
Juvenile Paget's disease with heterozygous duplication within TNFRSF11A encoding RANK
Whyte, M. P., Tau, C., McAlister, W. H., Zhang, X., Novack, D. V., de Preliasco, V. F., Santini‐Araujo, E., & Mumm, S. R. (2014) · Bone · doi:10.1016/j.bone.2014.07.019 · Cited by 52
Jimi, E., & Katagiri, T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147995 · Cited by 54
Permaul, P., Narla, A., Hornick, J. L., & Pai, S. (2009) · Immunologic Research · doi:10.1007/s12026-008-8085-2 · Cited by 51
Skeletal and extraskeletal actions of denosumab
Sinningen, K., Tsourdi, E. A., Rauner, M., Rachner, T. D., Hamann, C., & Hofbauer, L. C. (2012) · Endocrine · doi:10.1007/s12020-012-9696-x · Cited by 49
Mediero, A., Pérez‐Aso, M., & Cronstein, B. N. (2014) · The FASEB Journal · doi:10.1096/fj.14-255703 · Cited by 48
Reproductive toxicity of denosumab in cynomolgus monkeys
Bussiere, J. L., Pyrah, I. T. G., Boyce, R. W., Branstetter, D., Loomis, M., Andrews-Cleavenger, D., Farman, C. A., Elliott, G. S., & Chellman, G. J. (2013) · Reproductive Toxicology · doi:10.1016/j.reprotox.2013.07.018 · Cited by 43
Physiology and pathophysiology of the RANKL/RANK system
Hanada, R., Hanada, T., & Penninger, J. M. (2010) · Biological Chemistry · doi:10.1515/bc.2010.149 · Cited by 43
Stem cell transplantation for osteopetrosis in patients beyond the age of 5 years
Stepensky, P., Grisariu, S., Avni, B. R., Zaidman, I., Shadur, B., Elpeleg, O. N., Sirin, M., Hoenig, M., Schuetz, C., Furlan, I., et al. (2019) · Blood Advances · doi:10.1182/bloodadvances.2018025890 · Cited by 43
Whyte, M. P., Wenkert, D., McAlister, W. H., Novack, D. V., Nenninger, A. R., Zhang, X., Huskey, M., & Mumm, S. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.131 · Cited by 43
Whyte, M. P., Kempa, L. G., McAlister, W. H., Zhang, F., Mumm, S. R., & Wenkert, D. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.130 · Cited by 42
Palagano, E., Blair, H. C., Pangrazio, A., Tourkova, I. L., Strina, D., Angius, A., Cuccuru, G., Oppo, M., Uva, P., Hul, W. V., et al. (2015) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2517 · Cited by 42
Self-citationChung, P. Y. J., Beyens, G., Riches, P. L., Wesenbeeck, L. V., de Freitas, F., Jennes, K., Daroszewska, A., Fransén, E., Boonen, S., Geusens, P., et al. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.162 · Cited by 42
Jules, J., Shi, Z., Liu, J., Xu, D., Wang, S., & Feng, X. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.149484 · Cited by 41
A specific subtype of osteoclasts secretes factors inducing nodule formation by osteoblasts
Henriksen, K., Andreassen, K. V., Thudium, C. S., Gudmann, K. N. S., Moscatelli, I., Crüger-Hansen, C., Schulz, A., Dziegiel, M. H., Richter, J., Karsdal, M. A., et al. (2012) · Bone · doi:10.1016/j.bone.2012.06.007 · Cited by 40
Molecular mechanisms of triggering, amplifying and targeting RANK signaling in osteoclasts
Kuroda, Y. (2012) · World Journal of Orthopedics · doi:10.5312/wjo.v3.i11.167 · Cited by 42
Bone and bone marrow: The same organ
Fattore, A. D., Capannolo, M., & Rucci, N. (2010) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2010.07.020 · Cited by 42
Roles of ligands from the TNF superfamily in B cell development, function, and regulation
Figgett, W. A., Vincent, F. B., Saulep-Easton, D., & Mackay, F. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2014.06.001 · Cited by 38
Park‐Min, K., & Lorenzo, J. A. (2022) · Bone · doi:10.1016/j.bone.2022.116576 · Cited by 39
Interactions of B-lymphocytes and bone cells in health and disease
Grčević, D., Sanjay, A., & Lorenzo, J. (2023) · Bone · doi:10.1016/j.bone.2021.116296 · Cited by 36
Thudium, C. S., Moscatelli, I., Flores, C., Thomsen, J. S., Brüel, A., Gudmann, N. S., Hauge, E.-M., Karsdal, M. A., Richter, J., & Henriksen, K. (2014) · Calcified Tissue International · doi:10.1007/s00223-014-9865-4 · Cited by 36
The V–ATPase a3 subunit mutation R740S is dominant negative and results in osteopetrosis in mice
Ochotny, N., Flenniken, A. M., Owen, C., Voronov, I., Zirngibl, R. A., Osborne, L. R., Henderson, J. E., Adamson, S. L., Rossant, J., Manolson, M. F., et al. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.355 · Cited by 36
OPG/RANKL/RANK Pathway as a Therapeutic Target in Cancer
McGrath, E. E. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318229421f · Cited by 35
Denosumab for the treatment of osteoporosis
McClung, M. R. (2017) · Osteoporosis and Sarcopenia · doi:10.1016/j.afos.2017.01.002 · Cited by 36
A nonsynonymous TNFRSF11A variation increases NFκB activity and the severity of Paget's disease
Gianfrancesco, F., Rendina, D., Stefano, M. D., Mingione, A., Esposito, T., Merlotti, D., Gallone, S., Magliocca, S., Goode, A., Formicola, D., et al. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.542 · Cited by 33
Self-citationNovel mutations in Indian patients with autosomal recessive infantile malignant osteopetrosis.
Phadke, S. R., Fischer, B., Gupta, N., Ranganath, P., Kabra, M., & Kornak, U. (2010) · PubMed · Cited by 32
Metadata
- Authors
- Guerrini, M. M., Sobacchi, C., Cassani, B., Abinun, M., Kilic, S. S., Pangrazio, A., Moratto, D., Mazzolari, E., Clayton-Smith, J., Orchard, P., Coxon, F. P., Helfrich, M. H., Crockett, J. C., Mellis, D., Vellodi, A., Tezcan, I., Notarangelo, L. D., Rogers, M. J., Vezzoni, P., Villa, A., & Frattini, A.
- Affiliations
- Institute of Biomedical Technologies (IT)
- IRCCS Humanitas Research Hospital (IT)
- Newcastle University (GB)
- University of Brescia (IT)
- University of Minnesota (US)
- University of Aberdeen (GB)
- Great Ormond Street Hospital (GB)
- Harvard University (US)
- The San Raffaele Telethon Institute for Gene Therapy (IT)
- Corresponding author
- Villa, Anna
- ORCID
- Venue
- The American Journal of Human Genetics
- Publisher
- Elsevier BV
- Published
- 2008-07
- Volume
- 83
- Issue
- 1
- Pages
- 64-76
- ISSN
- 0002-9297 (ISSN-L)
- PMC
- PMC2443850
- OpenAlex
- W2040034328
- Cited by
- 309
- References
- 23
- Citations by year
- 2026: 9 · 2025: 13 · 2024: 8 · 2023: 2 · 2022: 17 · 2021: 12 · 2020: 24 · 2019: 19 · 2018: 11 · 2017: 21 · 2016: 17 · 2015: 17 · 2014: 24 · 2013: 18 · 2012: 24
- FWCI
- 9.93
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- The American Journal of Human Genetics (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Bursa Uludag University - AVESIS (submittedVersion)
- Hacettepe University Institutional Repository (hacettepe.edu.tr) (submittedVersion, other-oa)
- Research Explorer (The University of Manchester) (submittedVersion)
- Newcastle University ePrints (Newcastle Univesity)
- Funders
- E-Rare
- Fondazione Telethon
- Fondazione Cariplo
- Ministero dell’Istruzione, dell’Università e della Ricerca (RBIN04CHXT)
- Army Research Office
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
- Health Sciences › Medicine › Rheumatology › Osteomyelitis and Bone Disorders Research
- Keywords
- osteopetrosis, RANK, RANKL, hypogammaglobulinemia, osteoclastogenesis, B cell defect, immunodeficiency, consanguinity, autosomal recessive osteopetrosis, macrophage colony-stimulating factor, monocytes
- MeSH terms
- Tartrate-Resistant Acid Phosphatase, Acid Phosphatase, Actins, Agammaglobulinemia, Amino Acid Sequence, Argentina, Arginine, Biopsy, Cell Line, Transformed, Cell Transformation, Viral, Cells, Cultured, Consanguinity, Cysteine, Dendrites, DNA Mutational Analysis, Herpesvirus 4, Human, Female, Genes, Recessive, Heterozygote, Homozygote, Humans, Ilium, Isoenzymes, Leukocytes, Mononuclear, Lipopolysaccharides, Male, Molecular Sequence Data, Osteoclasts, Osteopetrosis, Pakistan, Pedigree, Polymorphism, Genetic, Radiography, Thoracic, Turkey, Cohort Studies, Case-Control Studies, Macrophage Colony-Stimulating Factor, Sequence Homology, Amino Acid, Protein Structure, Tertiary, Leukocyte Common Antigens, Models, Immunological, Receptors, Vitronectin, Amino Acid Substitution, Mutation, Missense, Cell Proliferation, Osteoprotegerin, RANK Ligand, Receptor Activator of Nuclear Factor-kappa B
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
